Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Evomela

(eh-voh-MEH-lah)
A drug that contains the active ingredient melphalan hydrochloride and is given as an infusion to prepare patients with multiple myeloma for a stem cell transplant. It is also being studied in the treatment of other types of cancer. Evomela may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent.
More Information
Search NCI's Dictionary of Cancer Terms